Skip to main content

Table 2 Demographics and characteristics of patients at baseline (n = 40)

From: Therapeutic evidence of umbilical cord-derived mesenchymal stem cell transplantation for cerebral palsy: a randomized, controlled trial

 

All (n = 40)

Control (n = 20)

hUC-MSC (n = 20)

P value

Demographics

 Sex, n (%)

1.000A

  Male

28 (70.0%)

14 (70.0%)

14 (70.0%)

 

  Female

12 (30.0%)

6 (30.0%)

6 (30.0%)

 

 Age, years, mean ± SEM

4.293 ± 0.397

4.755 ± 0.644

3.830 ± 0.459

0.249B

 History of preterm labor, n (%)

16 (40.0%)

7 (35.0%)

9 (45.0%)

0.519A

 Birth weight, kg, mean ± SEM

2.320 ± 0.042

2.395 ± 0.053

2.245 ± 0.062

0.072B

 History of rehabilitation, n (%)

11 (27.5%)

6 (30.0%)

5 (25.0%)

0.723A

MRI findings

 Brain maldevelopments, n (%)

23 (57.5%)

13 (65.0%)

10 (50.0%)

0.337A

 Cerebromalacia, n (%)

6 (15.0%)

3 (15.0%)

3 (15.0%)

0.658C

 Focal ischemia, n (%)

1 (2.5%)

0

1 (5.0%)

1.000D

 Corpus callosum agenesis, n (%)

1 (2.5%)

0

1 (5.0%)

1.000D

 Normal, n (%)

9 (22.5%)

4 (20.0%)

5 (25.0%)

1.000C

  1. Abbreviations: hUC-MSC human umbilical cord-derived mesenchymal stem cell, MRI magnetic resonance imaging
  2. AP value was calculated by χ2 test
  3. BP value was calculated by one-way ANOVA
  4. CP value was calculated by correction χ2 test
  5. DP value was calculated by Fisher’s exact test